Validation framework for epidemiological models with application to COVID-19 models.

PLoS Comput Biol

Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland, United States of America.

Published: March 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Mathematical models have been an important tool during the COVID-19 pandemic, for example to predict demand of critical resources such as medical devices, personal protective equipment and diagnostic tests. Many COVID-19 models have been developed. However, there is relatively little information available regarding reliability of model predictions. Here we present a general model validation framework for epidemiological models focused around predictive capability for questions relevant to decision-making end-users. COVID-19 models are typically comprised of multiple releases, and provide predictions for multiple localities, and these characteristics are systematically accounted for in the framework, which is based around a set of validation scores or metrics that quantify model accuracy of specific quantities of interest including: date of peak, magnitude of peak, rate of recovery, and monthly cumulative counts. We applied the framework to retrospectively assess accuracy of death predictions for four COVID-19 models, and accuracy of hospitalization predictions for one COVID-19 model (models for which sufficient data was publicly available). When predicting date of peak deaths, the most accurate model had errors of approximately 15 days or less, for releases 3-6 weeks in advance of the peak. Death peak magnitude relative errors were generally in the 50% range 3-6 weeks before peak. Hospitalization predictions were less accurate than death predictions. All models were highly variable in predictive accuracy across regions. Overall, our framework provides a wealth of information on the predictive accuracy of epidemiological models and could be used in future epidemics to evaluate new models or support existing modeling methodologies, and thereby aid in informed model-based public health decision making. The code for the validation framework is available at https://doi.org/10.5281/zenodo.7102854.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057797PMC
http://dx.doi.org/10.1371/journal.pcbi.1010968DOI Listing

Publication Analysis

Top Keywords

covid-19 models
16
validation framework
12
epidemiological models
12
models
11
framework epidemiological
8
peak magnitude
8
death predictions
8
predictions covid-19
8
hospitalization predictions
8
3-6 weeks
8

Similar Publications

Purpose: SARS-CoV-2 infection may lead to a worse prognosis in COVID-19 patients by inducing syncytia formation which implies intercellular transmission and immune evasion. Hesperidin (HSD) and hesperetin (HST) are two citrus flavonoids that demonstrate the potential to interfere with spike/human angiotensin-converting enzyme-2 (hACE2) binding and show an inhibitory effect in the SARS-CoV-2 pseudovirus internalization model. Here, we determined the effects of HSD and HST to inhibit syncytia formation using in vitro cell models.

View Article and Find Full Text PDF

Background: Metamemory is the awareness of and ability to evaluate one's own cognitive abilities. This study examined impaired metamemory as a possible mechanism contributing to persistent cognitive symptoms after COVID-19.

Methods: Individuals with previous COVID-19 illness were recruited.

View Article and Find Full Text PDF

Aims: The Norwegian Institute of Public Health calculated excess mortality for Norway in 2024 using a reference period that included 2023-a year with significant excess mortality-and concluded there was no excess mortality in 2024. This study estimates excess mortality in 2024 using only pre-pandemic years as the reference, providing a basis for identifying excess COVID-19 related mortality.

Methods: We estimated excess mortality in 2024 using a negative binomial model trained on 2010-2019 data.

View Article and Find Full Text PDF

Background: Coinciding with the SARS-CoV-2 pandemic, malaria cases and malaria-related deaths increased globally between 2020 and 2022. However, evidence linking the pandemic to increased malaria burden remains ambiguous. We assessed the extent to which an observed malaria resurgence in Lambaréné, Gabon, can be associated with pandemic-related disruptions in malaria control programmes.

View Article and Find Full Text PDF